- Lilly’s weight-loss drug cuts diabetes risk in overweight patientsReuters
- Tirzepatide cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker saysCNN
- Lilly weight loss drug prevents diabetes, company saysUSA TODAY
- Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trialCNBC
- Tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweightInvestors | Eli Lilly and Company